Explore syndication partnerships, co-investment mechanics, risk-sharing benefits, and governance considerations within private markets fundraising and capital flows.
Syndication and co-investment relationships have become pivotal tools across the private markets spectrum. From a personal perspective, I vividly recall the first time I assisted in a midsize buyout deal: our general partner (GP) recognized that the opportunity exceeded our single-investment limit—basically, we had a maximum amount the fund could dedicate to one target. So the GP invited partners from another fund to join. It felt almost like calling a friend to help carry a really heavy couch upstairs. That call made the difference, ensuring risk was spread out and the deal got done.
But there’s more to syndication than simply dividing the tab, and co-investments push that logic even further, creating an opportunity for limited partners (LPs) to invest directly in a company or project—often at better economic terms. If you’re thinking, “So, it’s mostly about saving on fees, right?” Well, sure, but it also changes the risk profile and governance structure. And it’s these nuances that matter most for your CFA exam and, frankly, your career in private investments.
Below, we’ll talk about what syndication and co-investment are, the mechanics behind them, their greatest benefits and hazards, plus best practices drawn from real-world experiences. Get comfortable—there’s a lot to unpack.
When a GP structures a deal syndication, they’re essentially inviting multiple investors to share in a single investment. This can happen if the deal size surpasses the GP’s single-investment limit or if specialized expertise is beneficial: maybe one investor is an industry expert, while another has unique geographic insights.
Syndication is also about sharing the love—and the load. Each syndicate member invests a portion of the equity, thereby diffusing capital exposure. The GP typically negotiates the main terms, but each participating LP or external investor has its own negotiated rights and obligations. Key items to watch include:
• Allocation of economics across participants
• Governance, including which investor has board representation
• Alignment on the exit strategy (timing, strategy, who calls the shots)
Communication across these parties is vital. Syndicated deals can shift direction if the GP’s plan changes, if some participants are short on capital calls, or in the (hopefully rare) case of a disagreement that triggers buy-sell clauses. You might be thinking, “Wow, that sounds complicated.” Indeed, it can be. But the advantage of harnessing multiple capital sources, specialized skill sets, and risk diversification often outweighs the complexity.
flowchart LR A["GP <br/>(General Partner)"] B["LP1 <br/>(Lead)"] C["LP2 <br/>Syndicate Partner"] D["LP3 <br/>Syndicate Partner"] E["Target Company <br/>or Project"] A --> E B --> E C --> E D --> E
In this diagram, the GP and multiple LPs (or syndicate partners) invest capital directly into the target company or project. Each party may hold a distinct ownership percentage, as set forth in a syndication agreement.
Co-investments let LPs invest alongside the main fund—often at a reduced or even zero management fee or carried interest. Here’s the typical scenario: the GP identifies a compelling investment opportunity, and the main fund invests up to its allowable threshold. But if there’s a gap or if the GP simply wants to minimize concentration in their fund, the GP offers selected LPs the “privilege” to put more capital into that very same deal, directly. Some see it as an opportunity for a bonus round—others see it as a concentrated risk to watch carefully.
• Lower Fees: Typically, co-investment capital is spared the layer of standard management fees and carried interest that apply to the main fund.
• Direct Exposure: LPs get a seat at the table (albeit a smaller one) to shape or review major decisions in a single company.
• Flexibility: LPs can be more selective—opting in for the deals they find most compelling.
• Concentration Risk: Putting more eggs in one basket if that co-investment is also a large chunk of the LP’s overall portfolio.
• More Demanding Diligence: LPs usually have a shorter window to evaluate the opportunity, and co-investment deals can move quickly.
• Potential Conflict: Some LPs might suspect that GPs reserve the best deals for themselves, while pushing out lesser ones to co-investment partners.
Whether you go the syndicate route or join a co-investment, keep your eyes on alignment. You don’t want to end up in a situation where the GP wants to exit in three years, but your key co-investor is itching for a quick flip in a year. Governance alignment clarifies:
• Decision rights (voting thresholds, board seats)
• Exit horizons and conditions (e.g., forced sale triggers, tag-along/drag-along rights)
• Follow-on capital decisions
If the deal environment changes—maybe there’s an economic downturn, or the target’s strategic pivot—strong governance ensures that none of the parties are blindsided. These aspects show up on the CFA exam in scenario-based questions. You might be presented with a complicated set of inputs: for instance, the GP’s desire for a quick exit vs. the co-investor’s preference to hold for synergy with another portfolio company. You’ll need to parse the best solution given the investment policy statement (IPS) restraints and the overarching portfolio strategy.
Most closed-end funds define a single investment limit in the partnership agreement. This is commonly 10–20% of total committed capital, though it varies by strategy. If a fund with $500 million in committed capital has a maximum single investment limit of 15%, that means any one deal cannot exceed $75 million from the fund. Here’s where syndication or co-investment can bridge the difference: the GP can bring in partners or offer co-investment rights so that the total deal size might be, say, $100 million or $125 million.
The primary reason for these limits is diversification. A fund with a single company comprising 50% of the portfolio is a high bet that can upend everything if that investment goes sour. Another angle is regulatory or internal risk policy frameworks—especially relevant for pension funds or insurance companies who must abide by risk-based capital rules.
From a numerical standpoint, these syndication and co-investment strategies also affect net returns. When co-investments bypass or reduce fees and carried interest, the difference in net IRR versus the main fund’s IRR can be notable. Imagine the net annual management fee is 2% and the carry is 20%. If an LP invests additional capital outside that fee structure, they keep that portion of the returns for themselves, net of only direct deal expenses.
Mathematically, the standard Internal Rate of Return (IRR) is the rate r such that the net present value (NPV) of cash flows is zero:
For a co-investment, you would discount your direct capital outflows and inflows separately from the main fund’s flows—resulting in a potentially higher net IRR if the investment performs well. However, keep in mind negative scenarios: a concentrated co-investment that goes bust will weigh heavily on your overall return.
Below is a tiny snippet of Python code that simulates how increasing your co-investment slice might affect your total portfolio volatility. (Don’t worry if you’re not a coding whiz; the script is meant to illustrate how you can model risk scenarios in a pinch.)
1import numpy as np
2
3np.random.seed(42)
4
5num_sims = 10_000
6base_returns = np.random.normal(loc=0.08, scale=0.15, size=num_sims) # 8% mean, 15% std dev
7coinv_returns = np.random.normal(loc=0.12, scale=0.25, size=num_sims) # 12% mean, 25% std dev
8
9for co_perc in [0.0, 0.05, 0.1, 0.2]: # fraction of entire portfolio used for co-invest
10 port_ret = (1 - co_perc)*base_returns + co_perc*coinv_returns
11 print(f"Co-invest at {co_perc*100:.0f}% -> Mean Return: {port_ret.mean():.2%}, Volatility: {port_ret.std():.2%}")
In this hypothetical, the co-investment is higher return on average but also higher volatility. Notice how, as you increase the fraction of your portfolio allocated to co-investments (co_perc), you might boost returns—but also your overall risk (standard deviation) climbs.
• Thorough Due Diligence: Resist the temptation to say “yes” to every co-investment. Conduct deal-specific analysis or outsource it to a trusted adviser.
• Strong Communication: Keep lines open between GP and all syndicate members. Everyone should be crystal clear on exit scenarios, capital calls, and governance.
• Align Incentives: Ensure the fee structure and carried interest split feel fair. As an LP, you want the GP to have “skin in the game.”
• Document Everything: Use robust side letters or subscription agreements that outline each party’s rights, obligations, and fees.
• Oversee Internal Compliance: For regulated institutions such as insurance companies or pension funds, ensure that adding syndicated or co-investment exposure adheres to capital requirements.
I once worked with a mid-sized pension fund that hopped on a co-investment deal involving a tech start-up. It was a dream: the GP was a well-known name, the star founder had an incredible track record, plus the co-investment terms were sweet—no management fee, half the standard carry. But after a year, the founder pivoted the company’s strategy drastically. The pension fund found itself heavily reliant on the GP’s judgment, with minimal say in daily operations. The relationship eventually led to tension, but having the right governance structure in place resolved most issues. Despite a rocky year, that company eventually soared in value, generating a net IRR well above the main fund’s performance. Moral of the story? The short-term storms can lead to big payoffs, provided you do your homework and keep an alignment in place.
For the CFA exam, especially at upper levels, you might be asked to:
• Evaluate an LP’s decision to accept a co-investment, factoring in risk constraints and fee reductions.
• Compare and contrast outcomes of a pure fund investment vs. a syndicated or co-investment stake.
• Navigate potential conflicts of interest or limited governance rights in a scenario-based question.
• Propose how to structure a side letter that addresses a co-investor’s unique needs.
It’s wise to practice scenario-based problems that incorporate real, tangible complexities—especially around fee waterfalls and alignment. Syndication and co-investment are not simply definitions on a page: they’re living processes that shape your portfolio’s risk and return profile.
• “Co-Investment in Private Markets” by Preqin
• “Syndicated Investments in Practice” – Harvard Business Review Case Studies
• CFA Institute Materials on Partnership Governance
• IFRS 10 & IFRS 12 for guidance on consolidation and disclosure of interest in other entities
Remember, if you’re approaching these structures in real life, spend time on the legal docs—you’ll thank yourself later!
• Read each scenario carefully—pay attention to the single investment limit, management fee structures, and potential conflicts of interest.
• Know the difference between net IRR from the main fund vs. the co-investment. Shifting fees and carried interest can exert a significant influence.
• Emphasize risk management, especially around a potential mismatch in time horizons or exit strategies among syndicate partners.
• If a question references reporting standards, consider IFRS or local GAAP regulations that might dictate consolidation or disclosures.
• When building your answer, connect the dots back to your portfolio’s overall strategic asset allocation. Don’t treat co-investments as an isolated pocket of capital.
Important Notice: FinancialAnalystGuide.com provides supplemental CFA study materials, including mock exams, sample exam questions, and other practice resources to aid your exam preparation. These resources are not affiliated with or endorsed by the CFA Institute. CFA® and Chartered Financial Analyst® are registered trademarks owned exclusively by CFA Institute. Our content is independent, and we do not guarantee exam success. CFA Institute does not endorse, promote, or warrant the accuracy or quality of our products.